Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
The emergence of therapy-resistant cancer stem cells (CSCs) limit the efficacy of prostate cancer treatment. Using genetic knockdown and chemical inhibitors, we demonstrate the critical role of Bromodomain Containing 4 (BRD4) in promoting mitochondrial fission and sustaining CSC expansion. These fin...
Main Authors: | Gianluca Civenni, Giuseppina M. Carbone, Carlo V. Catapano |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-09-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2019.1644598 |
Similar Items
-
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
by: Kenneth K. W. To, et al.
Published: (2023-03-01) -
The Functions of BET Proteins in Gene Transcription of Biology and Diseases
by: Ka Lung Cheung, et al.
Published: (2021-09-01) -
Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways
by: Sayilaxi Jieensinue, et al.
Published: (2018-09-01) -
Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation
by: Archit Trivedi, et al.
Published: (2020-03-01) -
Clinical and Biochemical Features in a Patient With Mitochondrial Fission Factor Gene Alteration
by: Alessia Nasca, et al.
Published: (2018-12-01)